Analysis of HCV quasispecies dynamic under selective pressure of combined therapy

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorJARDIM, Ana C. G.
dc.contributor.authorBITTAR, Cintia
dc.contributor.authorMATOS, Renata P. A.
dc.contributor.authorYAMASAKI, Lilian H. T.
dc.contributor.authorSILVA, Rafael A.
dc.contributor.authorPINHO, Joao R. R.
dc.contributor.authorFACHINI, Roberta M.
dc.contributor.authorCARARETO, Claudia M. A.
dc.contributor.authorCARVALHO-MELLO, Isabel M. V. G. de
dc.contributor.authorRAHAL, Paula
dc.date.accessioned2013-09-23T16:50:38Z
dc.date.available2013-09-23T16:50:38Z
dc.date.issued2013
dc.description.abstractBackground: The quasispecies composition of Hepatitis C virus (HCV) could have important implications with regard to viral persistence and response to interferon-based therapy. The complete NS5A was analyzed to evaluate whether the composition of NS5A quasispecies of HCV 1a/1b is related to responsiveness to combined interferon pegylated (PEG-IFN) and ribavirin therapy. Methods: Viral RNA was isolated from serum samples collected before, during and after treatment from virological sustained responder (SVR), non-responder (NR) and the end-of-treatment responder patients (ETR). NS5A region was amplified, cloned and sequenced. Six hundred and ninety full-length NS5A sequences were analyzed. Results: This study provides evidence that lower nucleotide diversity of the NS5A region pre-therapy is associated with viral clearance. Analysis of samples of NRs and the ETRs time points showed that genetic diversity of populations tend to decrease over time. Post-therapy population of ETRs presented higher genetic distance from baseline probably due to the bottleneck phenomenon observed for those patients in the end of treatment. The viral effective population of those patients also showed a strong decrease after therapy. Otherwise, NRs demonstrated a continuous variation or stability of effective populations and genetic diversity over time that did not seem to be related to therapy. Phylogenetic relationships concerning complete NS5A sequences obtained from patients did not demonstrate clustering associated with specific response patterns. However, distinctive clustering of pre/post-therapy sequences was observed. In addition, the evolution of quasispecies over time was subjected to purifying or relaxed purifying selection. Codons 157 (P03), 182 and 440 (P42), 62 and 404 (P44) were found to be under positive selective pressure but it failed to be related to the therapy. Conclusion: These results confirm the hypothesis that a relationship exists between NS5A heterogeneity and response to therapy in patients infected with chronic hepatitis C.
dc.description.indexMEDLINE
dc.description.sponsorshipFAPESP ""Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP"" [07/52073-0, 06/60012-9]
dc.identifier.citationBMC INFECTIOUS DISEASES, v.13, article ID 61, 16p, 2013
dc.identifier.doi10.1186/1471-2334-13-61
dc.identifier.issn1471-2334
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2281
dc.language.isoeng
dc.publisherBIOMED CENTRAL LTD
dc.relation.ispartofBMC Infectious Diseases
dc.rightsopenAccess
dc.rights.holderCopyright BIOMED CENTRAL LTD
dc.subject.otherhepatitis-c virus
dc.subject.othernonstructural protein 5a
dc.subject.otherhypervariable region 1
dc.subject.otherantiviral therapy
dc.subject.otherplus ribavirin
dc.subject.otherns5a protein
dc.subject.othergenotype 1b
dc.subject.othergenetic diversity
dc.subject.othersequence-analysis
dc.subject.otherinterferon
dc.subject.wosInfectious Diseases
dc.titleAnalysis of HCV quasispecies dynamic under selective pressure of combined therapy
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalJARDIM, Ana C. G.:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil
hcfmusp.author.externalBITTAR, Cintia:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil
hcfmusp.author.externalMATOS, Renata P. A.:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil; Univ Fed Sao Paulo, Div Gastroenterol, Lab Appl Mol Hepatol, Hepatitis Sect, Sao Paulo, Brazil
hcfmusp.author.externalYAMASAKI, Lilian H. T.:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil
hcfmusp.author.externalFACHINI, Roberta M.:Sao Jose do Rio Preto Sch Med, Dept Hepatol, Sao Paulo, Brazil
hcfmusp.author.externalCARARETO, Claudia M. A.:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil
hcfmusp.author.externalCARVALHO-MELLO, Isabel M. V. G. de:Univ Fed Sao Paulo, Div Gastroenterol, Lab Appl Mol Hepatol, Hepatitis Sect, Sao Paulo, Brazil
hcfmusp.author.externalRAHAL, Paula:Sao Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil
hcfmusp.citation.scopus14
hcfmusp.contributor.author-fmusphcJOAO RENATO REBELLO PINHO
hcfmusp.description.articlenumber61
hcfmusp.description.volume2013
hcfmusp.origemWOS
hcfmusp.origem.pubmed23374983
hcfmusp.origem.scopus2-s2.0-84873046412
hcfmusp.origem.wosWOS:000315901300001
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAppel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005
hcfmusp.relation.referenceAppel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
hcfmusp.relation.referenceBittar C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-36
hcfmusp.relation.referenceBrass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200
hcfmusp.relation.referenceChevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461
hcfmusp.relation.referenceCHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
hcfmusp.relation.referenceCuevas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003058
hcfmusp.relation.referenceDomingo E, 2006, CURR TOP MICROBIOL, V299, P51
hcfmusp.relation.referenceDrummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
hcfmusp.relation.referenceDuverlie G, 1998, J GEN VIROL, V79, P1373
hcfmusp.relation.referenceEnomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203
hcfmusp.relation.referenceENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025
hcfmusp.relation.referenceEwing B, 1998, GENOME RES, V8, P175
hcfmusp.relation.referenceEwing B, 1998, GENOME RES, V8, P186
hcfmusp.relation.referenceFan WM, 2005, J GASTROENTEROL, V40, P43, DOI 10.1007/s00535-004-1446-2
hcfmusp.relation.referenceFarci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599
hcfmusp.relation.referenceFiglerowicz M, 2010, ARCH VIROL, V155, P1977, DOI 10.1007/s00705-010-0789-7
hcfmusp.relation.referenceForns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8
hcfmusp.relation.referenceForns X., 1999, CLIN LIVER DIS, V3, pvii
hcfmusp.relation.referenceForns X, 1999, TRENDS MICROBIOL, V7, P402, DOI 10.1016/S0966-842X(99)01590-5
hcfmusp.relation.referenceFried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
hcfmusp.relation.referenceGaudy C, 2005, J CLIN MICROBIOL, V43, P750, DOI 10.1128/JCM.43.2.750-754.2005
hcfmusp.relation.referenceGerotto M, 2000, GASTROENTEROLOGY, V119, P1649, DOI 10.1053/gast.2000.20230
hcfmusp.relation.referenceHutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669
hcfmusp.relation.referenceGordon D, 1998, GENOME RES, V8, P195
hcfmusp.relation.referenceHall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI 10.1111/J.1469-8137.2009.02874.X
hcfmusp.relation.referenceIde Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0
hcfmusp.relation.referenceJain MK, 2009, J INFECT DIS, V200, P866, DOI 10.1086/605475
hcfmusp.relation.referenceJardim ACG, 2009, INFECT GENET EVOL, V9, P689, DOI 10.1016/j.meegid.2008.11.001
hcfmusp.relation.referenceLe Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416
hcfmusp.relation.referenceManns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
hcfmusp.relation.referenceMARTELL M, 1992, J VIROL, V66, P3225
hcfmusp.relation.referenceMarucci EA, 2008, GENET MOL RES, V7, P970
hcfmusp.relation.referenceMcCormack GP, 2002, REV MED VIROL, V12, P221, DOI 10.1002/rmv.355
hcfmusp.relation.referenceMoradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004
hcfmusp.relation.referenceMurphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06
hcfmusp.relation.referenceNousbaum JB, 2000, J VIROL, V74, P9028, DOI 10.1128/JVI.74.19.9028-9038.2000
hcfmusp.relation.referencePascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336
hcfmusp.relation.referencePawlotsky Jean-Michel, 2003, Clin Liver Dis, V7, P45, DOI 10.1016/S1089-3261(02)00065-X
hcfmusp.relation.referencePawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3
hcfmusp.relation.referencePawlotsky JM, 1998, J VIROL, V72, P2795
hcfmusp.relation.referencePawlotsky JM, 1999, J VIRAL HEPATITIS, V6, P343, DOI 10.1046/j.1365-2893.1999.00185.x
hcfmusp.relation.referencePawlotsky JM, 2005, SEMIN LIVER DIS, V25, P72, DOI 10.1055/s-2005-864783
hcfmusp.relation.referencePawlotsky JM, 1998, J MED VIROL, V54, P256, DOI 10.1002/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.3.CO;2-K
hcfmusp.relation.referencePellerin M, 2004, J VIROL, V78, P4617, DOI 10.1128/JVI.78.9.4617-4627.2004
hcfmusp.relation.referencePenin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200
hcfmusp.relation.referencePond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
hcfmusp.relation.referencePosada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
hcfmusp.relation.referencePuig-Basagoiti F, 2005, J GEN VIROL, V86, P1067, DOI 10.1099/vir.0.80526-0
hcfmusp.relation.referenceRamirez S, 2010, J GEN VIROL, V91, P1183, DOI 10.1099/vir.0.018929-0
hcfmusp.relation.referenceRay SC, 1999, J VIROL, V73, P2938
hcfmusp.relation.referenceSAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547
hcfmusp.relation.referenceSalmeron J, 2006, DIGEST DIS SCI, V51, P960, DOI 10.1007/s10620-006-9347-2
hcfmusp.relation.referenceSaludes V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014132
hcfmusp.relation.referenceSatoh S, 2000, VIROLOGY, V270, P476, DOI 10.1006/viro.2000.0287
hcfmusp.relation.referenceSauter D, 2009, J HEPATOL, V50, P861, DOI 10.1016/j.jhep.2008.11.024
hcfmusp.relation.referenceSimmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
hcfmusp.relation.referenceSwofford DL, 2003, VERSION 4
hcfmusp.relation.referenceTamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
hcfmusp.relation.referenceTellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200
hcfmusp.relation.referenceThompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
hcfmusp.relation.referenceToyoda H, 1997, J HEPATOL, V26, P6, DOI 10.1016/S0168-8278(97)80002-5
hcfmusp.relation.referenceUeda E, 2004, HEPATOL RES, V29, P89, DOI 10.1016/j.jhepres.2004.02.014
hcfmusp.relation.referenceWitherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1<8::AID-JMV1001>3.3.CO;2-B
hcfmusp.relation.referenceXu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08
hcfmusp.relation.referenceYang ZH, 1998, MOL BIOL EVOL, V15, P568
hcfmusp.relation.referenceYang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
hcfmusp.relation.referenceYang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9
hcfmusp.relation.referenceZekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-16
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication0ada2eb1-5ac2-4e40-b4e2-6af14f33268b
relation.isAuthorOfPublication.latestForDiscovery0ada2eb1-5ac2-4e40-b4e2-6af14f33268b
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_PINHO_Analysis_of_HCV_quasispecies_dynamic_under_selective_pressure_2013.PDF
Tamanho:
3.3 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)